Beifushu is a new biopharmaceutical product developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd. It is for the first time at home that a kind of eye drops can promote the cornea renovation and improve the cornea healing quality, so that it fills the gap in the field at home.
|
Pharmacological Actions:
The main component of Beifushu is recombinant bovine basic fibroblast growth factor ( rb-bFGF )
. Combined with the specific receptor on the surface of the target cell (including the epithelial and endothelial cells of the cornea and stoma cell) on the injury part , it can stimulate the active renovation function of the cell to promote the schizogamy , transplantation and differenti- ation of the corneal cell and to accelerate the healing of the corneal injury and improve the healing quality of the cornea.
|
Features:
* Protecting the cornea and promoting the regeneration of the cornea
* Accelerating the healing and shortening the healing period
* Renovating the cornea and speeding up the function resumption,
* Highly safe and non-toxic side effect.
|
Indications:
Various corneal defects and punctate keratopathy can be treated with the medicine.
* Recurrent punctate keratopathy in the shallow layer
* Geographical (or nutritional) single scar keratitis
* Corneal operation and delayed corneal healing after operation
* Ballous keratitis
* Corneal abrasion, mild and moderate chemical burns
* Xerophthalmia |
